Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

GREY WOLF THERAPEUTICS LIMITED

Company number 10989365

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
21 Jan 2020 SH10 Particulars of variation of rights attached to shares
21 Jan 2020 SH08 Change of share class name or designation
21 Jan 2020 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES12 ‐ Resolution of varying share rights or name
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
17 Jan 2020 SH03 Purchase of own shares.
07 Jan 2020 SH10 Particulars of variation of rights attached to shares
07 Jan 2020 SH08 Change of share class name or designation
03 Oct 2019 CS01 Confirmation statement made on 28 September 2019 with updates
06 Jul 2019 SH01 Statement of capital following an allotment of shares on 1 July 2019
  • GBP 504.4324
06 Jun 2019 SH01 Statement of capital following an allotment of shares on 31 May 2019
  • GBP 502.1877
20 May 2019 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
15 May 2019 AA Accounts for a small company made up to 31 December 2018
03 May 2019 RP04SH01 Second filing of a statement of capital following an allotment of shares on 9 December 2018
  • GBP 318.9795
03 May 2019 RP04SH01 Second filing of a statement of capital following an allotment of shares on 29 October 2018
  • GBP 318.8164
03 May 2019 RP04SH01 Second filing of a statement of capital following an allotment of shares on 10 October 2018
  • GBP 317.0223
18 Mar 2019 PSC02 Notification of Canaan Xi L.P. as a person with significant control on 12 February 2019
08 Mar 2019 PSC02 Notification of Biodiscovery 5 Fpci as a person with significant control on 12 February 2019
25 Feb 2019 SH01 Statement of capital following an allotment of shares on 12 February 2019
  • GBP 498.8356
10 Dec 2018 SH01 Statement of capital following an allotment of shares on 9 December 2018
  • GBP 318.9795
  • ANNOTATION Clarification a second filed SH01 was registered on 03/05/2019.
30 Oct 2018 SH01 Statement of capital following an allotment of shares on 29 October 2018
  • GBP 318.8164
  • ANNOTATION Clarification a second filed SH01 was registered on 03/05/2019.
18 Oct 2018 ANNOTATION Admin Removed Unnecessary material was administratively removed from the company record on 17/07/2019.
10 Oct 2018 SH01 Statement of capital following an allotment of shares on 10 October 2018
  • GBP 317.0194
  • ANNOTATION Clarification a second filed SH01 was registered on 03/05/2019.
10 Oct 2018 CS01 Confirmation statement made on 28 September 2018 with updates
18 May 2018 MA Memorandum and Articles of Association
23 Apr 2018 MA Memorandum and Articles of Association
19 Apr 2018 SH01 Statement of capital following an allotment of shares on 29 March 2018
  • GBP 313.1894